“Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo”. Iranian Journal of Kidney Diseases 18, no. 2 (June 11, 2024): 87–98. Accessed August 16, 2024. https://ijkd.org/index.php/ijkd/article/view/7546.